📰 Target Indication News
Page 3 - Target Indication News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Target Indication. Real-time updates on events, politics, business and more.
March 21, 2022
/PRNewswire/ -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases...
March 16, 2022
/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...
March 16, 2022
/PRNewswire/ -- The "Intranasal Therapeutics and Drug Delivery Systems Market Distribution by Target Indication, Type of Molecule and Geography: Industry...
March 16, 2022
/PRNewswire/ -- The "Intranasal Therapeutics and Drug Delivery Systems Market Distribution by Target Indication, Type of Molecule and Geography: Industry...
March 16, 2022
/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...
February 16, 2022
JERSEY CITY, N.J., Feb. 16, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Regulatory T-cells (Tregs) therapies Market
February 16, 2022
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Regulatory T-cells (Tregs) therapies Market...
April 6, 2021
Share this article Share this article ResearchAndMarkets.coms offering. Since the approval of Vitravene (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development. Examples of recently approved antisense therapeutics include (in reverse chronological order) Viltepso (duc...